MPR rolls out revamped website

Share this article:
Monthly Prescribing Reference (MPR) has relaunched its website with a number of enhancements to functionality and design, as well as a new, easier-to-remember URL, www.eMPR.com.

The new site will continue to focus on drug information but now offers a beefed-up search capability that can filter information according to a number of different criteria, including relevance, therapeutic category and date.
Furthermore, accompanying each drug monograph is a series of related resource options, such as drug news, sponsored alerts, pharmacology notes, clinical charts, similar drugs and recent updates to the data. Also, users are now able to compare drugs, side by side.

The redesigned site is easier to navigate and now features links to related sites, such as www.myCME.com. It also offers a much wider range of options for sponsors.

Physicians have been using the print editions of MPR for more than 25 years, and Jim Pantaleo, MPR vice president and publisher, says the new site is part of an initiative to offer up-to-date, concise drug information to healthcare professionals during every part of their day and in the medium of their choice.

MPR is published by Prescribing Reference, Inc., part of Haymarket Media, which also publishes MM&M.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.